Serum Interleukin- 6, Tumor Necrosis Factor-α, D-Dimer after recombinant human brain natriuretic peptide combined with levosimendan in patients with heart failure
serum markers after heart failure treatment
Ključne reči:
0
Sažetak
0
Reference
Agarwala, P., and Salzman, S. H. (2020). Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.Chest 157:603-611. doi:10.1016/j.chest.2019.10.014
Beitzke, D., Gremmel, F., Senn, D., Laggner, R., Kammerlander, A., Wielandner, A., Nolz, R., Hülsmann, M., and Loewe, C. (2021). Effects of Levosimendan on cardiac function, size and strain in heart failure patients.Int J Cardiovasc Imaging 37:1063-1071. doi:10.1007/s10554-020-02077-z
Boivin-Jahns, V., Jahns, R., and Boege, F. (2018). Relevant effects of beta(1)-adrenoceptor autoantibodies in chronic heart failure.Front Biosci (Landmark Ed) 23:2146-2156. doi:10.2741/4695
Burkhoff, D., Rich, S., Pollesello, P., and Papp, Z. (2021). Levosimendan-induced venodilation is mediated by opening of potassium channels.ESC Heart Fail 8:4454-4464. doi:10.1002/ehf2.13669
Castiglione, V., Aimo, A., Vergaro, G., Saccaro, L., Passino, C., and Emdin, M. (2022). Biomarkers for the diagnosis and management of heart failure.Heart Fail Rev 27:625-643. doi:10.1007/s10741-021-10105-w
Comín-Colet, J., Manito, N., Segovia-Cubero, J., Delgado, J., García Pinilla, J. M., Almenar, L., Crespo-Leiro, M. G., Sionis, A., Blasco, T., Pascual-Figal, D., Gonzalez-Vilchez, F., Lambert-Rodríguez, J. L., Grau, M., and Bruguera, J. (2018). Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.Eur J Heart Fail 20:1128-1136. doi:10.1002/ejhf.1145
Cook, C., Cole, G., Asaria, P., Jabbour, R., and Francis, D. P. (2014). The annual global economic burden of heart failure.Int J Cardiol 171:368-376. doi:10.1016/j.ijcard.2013.12.028
de Denus, S., Pharand, C., and Williamson, D. R. (2004). Brain natriuretic peptide in the management of heart failure: the versatile neurohormone.Chest 125:652-668. doi:10.1378/chest.125.2.652
Dick, S. A., and Epelman, S. (2016). Chronic Heart Failure and Inflammation: What Do We Really Know?Circ Res 119:159-176. doi:10.1161/circresaha.116.308030
Dutka, M., Bobiński, R., Ulman-Włodarz, I., Hajduga, M., Bujok, J., Pająk, C., and Ćwiertnia, M. (2020). Various aspects of inflammation in heart failure.Heart Fail Rev 25:537-548. doi:10.1007/s10741-019-09875-1
Eijsvogels, T. M. H., Maessen, M. F. H., Bakker, E. A., Meindersma, E. P., van Gorp, N., Pijnenburg, N., Thompson, P. D., and Hopman, M. T. E. (2020). Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands.JAMA Netw Open 3:e2011686. doi:10.1001/jamanetworkopen.2020.11686
Hanna, A., and Frangogiannis, N. G. (2020). Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.Cardiovasc Drugs Ther 34:849-863. doi:10.1007/s10557-020-07071-0
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., . . . Yancy, C. W. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation 145:e895-e1032. doi:10.1161/cir.0000000000001063
Heidenreich, P. A., Fonarow, G. C., Opsha, Y., Sandhu, A. T., Sweitzer, N. K., and Warraich, H. J. (2022). Economic Issues in Heart Failure in the United States.J Card Fail 28:453-466. doi:10.1016/j.cardfail.2021.12.017
Hersberger, L., Dietz, A., Bürgler, H., Bargetzi, A., Bargetzi, L., Kägi-Braun, N., Tribolet, P., Gomes, F., Hoess, C., Pavlicek, V., Bilz, S., Sigrist, S., Brändle, M., Henzen, C., Thomann, R., Rutishauser, J., Aujesky, D., Rodondi, N., Donzé, J., . . . Schuetz, P. (2021). Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.J Am Coll Cardiol 77:2307-2319. doi:10.1016/j.jacc.2021.03.232
Hobbs, F. D., Roalfe, A. K., Davis, R. C., Davies, M. K., and Hare, R. (2007). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).Eur Heart J 28:1128-1134. doi:10.1093/eurheartj/ehm102
Kourek, C., Briasoulis, A., Giamouzis, G., Skoularigis, J., and Xanthopoulos, A. (2023). Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure.World J Clin Cases 11:8603-8605. doi:10.12998/wjcc.v11.i36.8603
Kuwahara, K. (2021). The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.Pharmacol Ther 227:107863. doi:10.1016/j.pharmthera.2021.107863
Li, F., Li, H., Luo, R., Pei, J. B., and Yu, X. Y. (2023). Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation.World J Clin Cases 11:6066-6072. doi:10.12998/wjcc.v11.i26.6066
Li, N., and Dobrev, D. (2018). Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?Naunyn Schmiedebergs Arch Pharmacol 391:231-233. doi:10.1007/s00210-018-1463-y
Li, X., Peng, H., Wu, J., and Xu, Y. (2018). Brain Natriuretic Peptide-Regulated Expression of Inflammatory Cytokines in Lipopolysaccharide (LPS)-Activated Macrophages via NF-κB and Mitogen Activated Protein Kinase (MAPK) Pathways.Med Sci Monit 24:3119-3126. doi:10.12659/msm.905580
Loncar, G., Fülster, S., von Haehling, S., and Popovic, V. (2013). Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure.Int J Cardiol 162:77-85. doi:10.1016/j.ijcard.2011.09.079
Martínez-González, M. A., Gea, A., and Ruiz-Canela, M. (2019). The Mediterranean Diet and Cardiovascular Health.Circ Res 124:779-798. doi:10.1161/circresaha.118.313348
McMurray, J. J., and Pfeffer, M. A. (2005). Heart failure.Lancet 365:1877-1889. doi:10.1016/s0140-6736(05)66621-4
Meijers, W. C., and de Boer, R. A. (2019). Common risk factors for heart failure and cancer.Cardiovasc Res 115:844-853. doi:10.1093/cvr/cvz035
Motoki, H., Nishimura, M., Kanai, M., Kimura, K., Minamisawa, M., Yamamoto, S., Saigusa, T., Ebisawa, S., Okada, A., and Kuwahara, K. (2019). Impact of inpatient cardiac rehabilitation on Barthel Index score and prognosis in patients with acute decompensated heart failure.Int J Cardiol 293:125-130. doi:10.1016/j.ijcard.2019.06.071
Moudgil, R., and Haddad, H. (2013). Depression in heart failure.Curr Opin Cardiol 28:249-258. doi:10.1097/HCO.0b013e32835ced80
Norman, K., Pichard, C., Lochs, H., and Pirlich, M. (2008). Prognostic impact of disease-related malnutrition.Clin Nutr 27:5-15. doi:10.1016/j.clnu.2007.10.007
Okuyama, R., Ishii, J., Takahashi, H., Kawai, H., Muramatsu, T., Harada, M., Yamada, A., Motoyama, S., Matsui, S., Naruse, H., Sarai, M., Hasegawa, M., Watanabe, E., Suzuki, A., Hayashi, M., Izawa, H., Yuzawa, Y., and Ozaki, Y. (2017). Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.Heart Vessels 32:880-892. doi:10.1007/s00380-017-0948-9
Parovic, M., Okwose, N. C., Bailey, K., Velicki, L., Fras, Z., Seferovic, P. M., MacGowan, G. A., and Jakovljevic, D. G. (2019). NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.ESC Heart Fail 6:449-454. doi:10.1002/ehf2.12424
Roger, V. L. (2021). Epidemiology of Heart Failure: A Contemporary Perspective.Circ Res 128:1421-1434. doi:10.1161/circresaha.121.318172
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., and Coats, A. J. S. (2023). Global burden of heart failure: a comprehensive and updated review of epidemiology.Cardiovasc Res 118:3272-3287. doi:10.1093/cvr/cvac013
Schuetz, P. (2015). "Eat your lunch!" - controversies in the nutrition of the acutely, non-critically ill medical inpatient.Swiss Med Wkly 145:w14132. doi:10.4414/smw.2015.14132
Schütz, P., Bally, M., Stanga, Z., and Keller, U. (2014). Loss of appetite in acutely ill medical inpatients: physiological response or therapeutic target?Swiss Med Wkly 144:w13957. doi:10.4414/smw.2014.13957
Sciatti, E., Lombardi, C., Ravera, A., Vizzardi, E., Bonadei, I., Carubelli, V., Gorga, E., and Metra, M. (2016). Nutritional Deficiency in Patients with Heart Failure.Nutrients 8. doi:10.3390/nu8070442
Shi, J., Chen, Y., Zhi, H., An, H., and Hu, Z. (2022). Levosimendan protects from sepsis-inducing cardiac dysfunction by suppressing inflammation, oxidative stress and regulating cardiac mitophagy via the PINK-1-Parkin pathway in mice.Ann Transl Med 10:212. doi:10.21037/atm-22-483
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J. C., Szczeklik, W., van Zanten, A. R. H., and Bischoff, S. C. (2023). ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit.Clin Nutr 42:1671-1689. doi:10.1016/j.clnu.2023.07.011
Tsutsui, H., Albert, N. M., Coats, A. J. S., Anker, S. D., Bayes-Genis, A., Butler, J., Chioncel, O., Defilippi, C. R., Drazner, M. H., Felker, G. M., Filippatos, G., Fiuzat, M., Ide, T., Januzzi, J. L., Jr., Kinugawa, K., Kuwahara, K., Matsue, Y., Mentz, R. J., Metra, M., . . . Yoshimura, M. (2023). Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.Eur J Heart Fail 25:616-631. doi:10.1002/ejhf.2848
Vellas, B., Guigoz, Y., Garry, P. J., Nourhashemi, F., Bennahum, D., Lauque, S., and Albarede, J. L. (1999). The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients.Nutrition 15:116-122. doi:10.1016/s0899-9007(98)00171-3
Vest, A. R., Chan, M., Deswal, A., Givertz, M. M., Lekavich, C., Lennie, T., Litwin, S. E., Parsly, L., Rodgers, J. E., Rich, M. W., Schulze, P. C., Slader, A., and Desai, A. (2019). Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee.J Card Fail 25:380-400. doi:10.1016/j.cardfail.2019.03.007
Wondifraw, H. (2020). a systematic analysis for the Global Burden of Disease Study 2017. GBD 2017 Causes of Death Collaborators. Lancet 2018; 392: 1736–88.
Xiangli, S., Lan, L., Libiya, Z., Jun, M., and Shubin, J. (2021). Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance.Libyan J Med 16:1973762. doi:10.1080/19932820.2021.1973762
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Jr., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., Johnson, M. R., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., McMurray, J. J., Mitchell, J. E., Peterson, P. N., Riegel, B., . . . Wilkoff, B. L. (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation 128:e240-327. doi:10.1161/CIR.0b013e31829e8776
Beitzke, D., Gremmel, F., Senn, D., Laggner, R., Kammerlander, A., Wielandner, A., Nolz, R., Hülsmann, M., and Loewe, C. (2021). Effects of Levosimendan on cardiac function, size and strain in heart failure patients.Int J Cardiovasc Imaging 37:1063-1071. doi:10.1007/s10554-020-02077-z
Boivin-Jahns, V., Jahns, R., and Boege, F. (2018). Relevant effects of beta(1)-adrenoceptor autoantibodies in chronic heart failure.Front Biosci (Landmark Ed) 23:2146-2156. doi:10.2741/4695
Burkhoff, D., Rich, S., Pollesello, P., and Papp, Z. (2021). Levosimendan-induced venodilation is mediated by opening of potassium channels.ESC Heart Fail 8:4454-4464. doi:10.1002/ehf2.13669
Castiglione, V., Aimo, A., Vergaro, G., Saccaro, L., Passino, C., and Emdin, M. (2022). Biomarkers for the diagnosis and management of heart failure.Heart Fail Rev 27:625-643. doi:10.1007/s10741-021-10105-w
Comín-Colet, J., Manito, N., Segovia-Cubero, J., Delgado, J., García Pinilla, J. M., Almenar, L., Crespo-Leiro, M. G., Sionis, A., Blasco, T., Pascual-Figal, D., Gonzalez-Vilchez, F., Lambert-Rodríguez, J. L., Grau, M., and Bruguera, J. (2018). Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.Eur J Heart Fail 20:1128-1136. doi:10.1002/ejhf.1145
Cook, C., Cole, G., Asaria, P., Jabbour, R., and Francis, D. P. (2014). The annual global economic burden of heart failure.Int J Cardiol 171:368-376. doi:10.1016/j.ijcard.2013.12.028
de Denus, S., Pharand, C., and Williamson, D. R. (2004). Brain natriuretic peptide in the management of heart failure: the versatile neurohormone.Chest 125:652-668. doi:10.1378/chest.125.2.652
Dick, S. A., and Epelman, S. (2016). Chronic Heart Failure and Inflammation: What Do We Really Know?Circ Res 119:159-176. doi:10.1161/circresaha.116.308030
Dutka, M., Bobiński, R., Ulman-Włodarz, I., Hajduga, M., Bujok, J., Pająk, C., and Ćwiertnia, M. (2020). Various aspects of inflammation in heart failure.Heart Fail Rev 25:537-548. doi:10.1007/s10741-019-09875-1
Eijsvogels, T. M. H., Maessen, M. F. H., Bakker, E. A., Meindersma, E. P., van Gorp, N., Pijnenburg, N., Thompson, P. D., and Hopman, M. T. E. (2020). Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands.JAMA Netw Open 3:e2011686. doi:10.1001/jamanetworkopen.2020.11686
Hanna, A., and Frangogiannis, N. G. (2020). Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.Cardiovasc Drugs Ther 34:849-863. doi:10.1007/s10557-020-07071-0
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., . . . Yancy, C. W. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation 145:e895-e1032. doi:10.1161/cir.0000000000001063
Heidenreich, P. A., Fonarow, G. C., Opsha, Y., Sandhu, A. T., Sweitzer, N. K., and Warraich, H. J. (2022). Economic Issues in Heart Failure in the United States.J Card Fail 28:453-466. doi:10.1016/j.cardfail.2021.12.017
Hersberger, L., Dietz, A., Bürgler, H., Bargetzi, A., Bargetzi, L., Kägi-Braun, N., Tribolet, P., Gomes, F., Hoess, C., Pavlicek, V., Bilz, S., Sigrist, S., Brändle, M., Henzen, C., Thomann, R., Rutishauser, J., Aujesky, D., Rodondi, N., Donzé, J., . . . Schuetz, P. (2021). Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.J Am Coll Cardiol 77:2307-2319. doi:10.1016/j.jacc.2021.03.232
Hobbs, F. D., Roalfe, A. K., Davis, R. C., Davies, M. K., and Hare, R. (2007). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).Eur Heart J 28:1128-1134. doi:10.1093/eurheartj/ehm102
Kourek, C., Briasoulis, A., Giamouzis, G., Skoularigis, J., and Xanthopoulos, A. (2023). Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure.World J Clin Cases 11:8603-8605. doi:10.12998/wjcc.v11.i36.8603
Kuwahara, K. (2021). The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.Pharmacol Ther 227:107863. doi:10.1016/j.pharmthera.2021.107863
Li, F., Li, H., Luo, R., Pei, J. B., and Yu, X. Y. (2023). Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation.World J Clin Cases 11:6066-6072. doi:10.12998/wjcc.v11.i26.6066
Li, N., and Dobrev, D. (2018). Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?Naunyn Schmiedebergs Arch Pharmacol 391:231-233. doi:10.1007/s00210-018-1463-y
Li, X., Peng, H., Wu, J., and Xu, Y. (2018). Brain Natriuretic Peptide-Regulated Expression of Inflammatory Cytokines in Lipopolysaccharide (LPS)-Activated Macrophages via NF-κB and Mitogen Activated Protein Kinase (MAPK) Pathways.Med Sci Monit 24:3119-3126. doi:10.12659/msm.905580
Loncar, G., Fülster, S., von Haehling, S., and Popovic, V. (2013). Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure.Int J Cardiol 162:77-85. doi:10.1016/j.ijcard.2011.09.079
Martínez-González, M. A., Gea, A., and Ruiz-Canela, M. (2019). The Mediterranean Diet and Cardiovascular Health.Circ Res 124:779-798. doi:10.1161/circresaha.118.313348
McMurray, J. J., and Pfeffer, M. A. (2005). Heart failure.Lancet 365:1877-1889. doi:10.1016/s0140-6736(05)66621-4
Meijers, W. C., and de Boer, R. A. (2019). Common risk factors for heart failure and cancer.Cardiovasc Res 115:844-853. doi:10.1093/cvr/cvz035
Motoki, H., Nishimura, M., Kanai, M., Kimura, K., Minamisawa, M., Yamamoto, S., Saigusa, T., Ebisawa, S., Okada, A., and Kuwahara, K. (2019). Impact of inpatient cardiac rehabilitation on Barthel Index score and prognosis in patients with acute decompensated heart failure.Int J Cardiol 293:125-130. doi:10.1016/j.ijcard.2019.06.071
Moudgil, R., and Haddad, H. (2013). Depression in heart failure.Curr Opin Cardiol 28:249-258. doi:10.1097/HCO.0b013e32835ced80
Norman, K., Pichard, C., Lochs, H., and Pirlich, M. (2008). Prognostic impact of disease-related malnutrition.Clin Nutr 27:5-15. doi:10.1016/j.clnu.2007.10.007
Okuyama, R., Ishii, J., Takahashi, H., Kawai, H., Muramatsu, T., Harada, M., Yamada, A., Motoyama, S., Matsui, S., Naruse, H., Sarai, M., Hasegawa, M., Watanabe, E., Suzuki, A., Hayashi, M., Izawa, H., Yuzawa, Y., and Ozaki, Y. (2017). Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.Heart Vessels 32:880-892. doi:10.1007/s00380-017-0948-9
Parovic, M., Okwose, N. C., Bailey, K., Velicki, L., Fras, Z., Seferovic, P. M., MacGowan, G. A., and Jakovljevic, D. G. (2019). NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.ESC Heart Fail 6:449-454. doi:10.1002/ehf2.12424
Roger, V. L. (2021). Epidemiology of Heart Failure: A Contemporary Perspective.Circ Res 128:1421-1434. doi:10.1161/circresaha.121.318172
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., and Coats, A. J. S. (2023). Global burden of heart failure: a comprehensive and updated review of epidemiology.Cardiovasc Res 118:3272-3287. doi:10.1093/cvr/cvac013
Schuetz, P. (2015). "Eat your lunch!" - controversies in the nutrition of the acutely, non-critically ill medical inpatient.Swiss Med Wkly 145:w14132. doi:10.4414/smw.2015.14132
Schütz, P., Bally, M., Stanga, Z., and Keller, U. (2014). Loss of appetite in acutely ill medical inpatients: physiological response or therapeutic target?Swiss Med Wkly 144:w13957. doi:10.4414/smw.2014.13957
Sciatti, E., Lombardi, C., Ravera, A., Vizzardi, E., Bonadei, I., Carubelli, V., Gorga, E., and Metra, M. (2016). Nutritional Deficiency in Patients with Heart Failure.Nutrients 8. doi:10.3390/nu8070442
Shi, J., Chen, Y., Zhi, H., An, H., and Hu, Z. (2022). Levosimendan protects from sepsis-inducing cardiac dysfunction by suppressing inflammation, oxidative stress and regulating cardiac mitophagy via the PINK-1-Parkin pathway in mice.Ann Transl Med 10:212. doi:10.21037/atm-22-483
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J. C., Szczeklik, W., van Zanten, A. R. H., and Bischoff, S. C. (2023). ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit.Clin Nutr 42:1671-1689. doi:10.1016/j.clnu.2023.07.011
Tsutsui, H., Albert, N. M., Coats, A. J. S., Anker, S. D., Bayes-Genis, A., Butler, J., Chioncel, O., Defilippi, C. R., Drazner, M. H., Felker, G. M., Filippatos, G., Fiuzat, M., Ide, T., Januzzi, J. L., Jr., Kinugawa, K., Kuwahara, K., Matsue, Y., Mentz, R. J., Metra, M., . . . Yoshimura, M. (2023). Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.Eur J Heart Fail 25:616-631. doi:10.1002/ejhf.2848
Vellas, B., Guigoz, Y., Garry, P. J., Nourhashemi, F., Bennahum, D., Lauque, S., and Albarede, J. L. (1999). The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients.Nutrition 15:116-122. doi:10.1016/s0899-9007(98)00171-3
Vest, A. R., Chan, M., Deswal, A., Givertz, M. M., Lekavich, C., Lennie, T., Litwin, S. E., Parsly, L., Rodgers, J. E., Rich, M. W., Schulze, P. C., Slader, A., and Desai, A. (2019). Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee.J Card Fail 25:380-400. doi:10.1016/j.cardfail.2019.03.007
Wondifraw, H. (2020). a systematic analysis for the Global Burden of Disease Study 2017. GBD 2017 Causes of Death Collaborators. Lancet 2018; 392: 1736–88.
Xiangli, S., Lan, L., Libiya, Z., Jun, M., and Shubin, J. (2021). Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance.Libyan J Med 16:1973762. doi:10.1080/19932820.2021.1973762
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Jr., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., Johnson, M. R., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., McMurray, J. J., Mitchell, J. E., Peterson, P. N., Riegel, B., . . . Wilkoff, B. L. (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation 128:e240-327. doi:10.1161/CIR.0b013e31829e8776
Objavljeno
2025/03/25
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Yujing Zhang
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.